These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2466781)
1. Cytochemical characterization of mouse L1210 leukemia. Kawiak J; Skórski T; Ciechanowicz A; Zylińska M; Seidel HJ; Kawalec M; Gnatowski B; Czarnomska A Immunol Invest; 1988; 17(6-7):543-50. PubMed ID: 2466781 [TBL] [Abstract][Full Text] [Related]
2. Establishment of a murine leukemia L1210-specific T-cell clone displaying novel in vivo anti-tumor activity. Nagase F; Ueda K; Nakashima I; Kawashima K; Isobe K; Nagura E; Yamada K; Yokochi T; Hasegawa Y; Yoshida T Int J Cancer; 1986 Dec; 38(6):907-14. PubMed ID: 3491792 [TBL] [Abstract][Full Text] [Related]
3. Peanut agglutinin. II. Characterization of the Thy-1, Tla and Ig phenotype of peanut agglutinin-positive cells in adult, embryonic and nude mice using double immunofluorescence. Roelants GE; London J; Mayor-Withey KS; Serrano B Eur J Immunol; 1979 Feb; 9(2):139-45. PubMed ID: 312207 [TBL] [Abstract][Full Text] [Related]
4. A normal component in ribbit IgG with affinity for mouse tissues. Witz I; Yagi Y; Pressman D Immunology; 1968 Nov; 15(5):765-72. PubMed ID: 5697019 [TBL] [Abstract][Full Text] [Related]
5. Serological analysis of H-2 antigens expression on the cell surface of drug- and lectin-resistant mouse tumor cells. Opolski A; Duś D; Radzikowski C Arch Immunol Ther Exp (Warsz); 1986; 34(1):21-34. PubMed ID: 3778114 [TBL] [Abstract][Full Text] [Related]
6. Early induction of immune resistance against leukemia in lethally total body irradiated mice reconstituted with syngeneic bone marrow cells obtained from previously immunized donor mice. Skorski T; Kawalec M; Kawiak J Bone Marrow Transplant; 1990 Jan; 5(1):23-7. PubMed ID: 2297588 [TBL] [Abstract][Full Text] [Related]
7. Studies on cell surface antigens of mouse leukemic and normal lymphocytes. II. Relationships between mammary leukemia, gross virus related and major histocompatibility antigens on L1210 leukemic lymphocytes. Steuden J; Strzadała L; Radzikowski C Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):95-7. PubMed ID: 219815 [TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera. Yokochi T; Kawashima K; Nakashima I; Nagase F; Isobe K; Nagura E; Yamada K; Miyadai T; Kimura Y Cancer Res; 1987 Feb; 47(4):1006-9. PubMed ID: 3542198 [TBL] [Abstract][Full Text] [Related]
10. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies. Rapp L; Fuji H Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755 [TBL] [Abstract][Full Text] [Related]
12. T cell hybrids that express a VH idiotope-related determinant on a glycoprotein distinct from H-2, Thy-1, and Lyt-1 molecules. Chanh TC; Cooper MD J Exp Med; 1983 Aug; 158(2):452-64. PubMed ID: 6193222 [TBL] [Abstract][Full Text] [Related]
13. Serological identification of viral and virus-related antigens on DBA/2 mouse leukemia lymphocytes. Steuden I; Radzikowski C; Zak-Nejmark T Arch Immunol Ther Exp (Warsz); 1979; 27(1-2):187-207. PubMed ID: 220930 [TBL] [Abstract][Full Text] [Related]
14. Dynamics of generation of antigen loss variants from L1210 murine leukemia clones detected by a tumor-specific T-cell clone. Nagase F; Rahman SM; Yokochi T; Kawashima K; Isobe K; Yoshida T; Nagura E; Nakashima I Cancer Res; 1987 Dec; 47(24 Pt 1):6494-9. PubMed ID: 3499976 [TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of cell surface markers on murine NK cells and CTL target-effector conjugates. Beaumont TJ; Roder JC; Elliott BE; Kerbel RS; Dennis JW; Kasai M; Okumura K Scand J Immunol; 1982 Aug; 16(2):123-33. PubMed ID: 6127796 [TBL] [Abstract][Full Text] [Related]
16. Origin of autoreactive T helper cells. I. Characterization of Thy-1+, Lyt-, L3T4- precursors in the spleen of normal mice. de Talance A; Regnier D; Spinella S; Morisset J; Seman M J Immunol; 1986 Aug; 137(4):1101-8. PubMed ID: 2426351 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline. Testorelli C; Archetti YL; Aresca P; Del Vecchio L Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006 [TBL] [Abstract][Full Text] [Related]
18. Leukemia L 1210 cells induce depletion of Lyt 2+ thymocytes. Kawiak J; Kawalec M Folia Histochem Cytobiol; 1990; 28(1-2):15-7. PubMed ID: 2097178 [TBL] [Abstract][Full Text] [Related]
19. Participation of T-lymphocytes in the curative effect of a novel synthetic polyamine analogue, N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine, against L1210 leukemia in vivo. Bowlin TL; Prakash NJ; Edwards ML; Sjoerdsma A Cancer Res; 1991 Jan; 51(1):62-6. PubMed ID: 1988107 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of T cell-mediated cytolysis: an investigation of cells and stages affected by cytolysis-inhibiting monoclonal antibodies. Hayot B; Pierres M; Golstein P Adv Exp Med Biol; 1982; 146():469-85. PubMed ID: 6980571 [No Abstract] [Full Text] [Related] [Next] [New Search]